MargaretAFischlMD

Internal Medicine • Miami, FL

HIV/AIDS Medicine

Professor of Medicine, University Miami School of Medicine

Join to view full profile

Dr. Fischl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fischl's full profile

Already have an account?

Office
1611 NW 12th Ave
# M851
Miami, FL 33136
Phone+1 305-243-6484

Fax+1 305-243-8470

Education & Training

University of Miami/Jackson Health SystemResidency, Internal Medicine, 1976 - 1979
University of Miami Leonard M. Miller School of MedicineClass of 1976

Certifications & Licensure

FL State Medical License 1977 - 2027
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen
Completed
Phase 3
A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients
Completed
Phase 2
A Study of Patients Who Recently Have Been Infected With HIV
Withdrawn
Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen
Completed
Not Applicable
Buprenorphine and Integrated HIV Care Evaluation Start of enrollment: 2005 Aug 01
Unknown status
Phase 4
Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive Start of enrollment: 2006 Oct 01
Terminated
Phase 1
Buprenorphine HIV Care Integration Project Start of enrollment: 2006 Jul 01
Completed
Not Applicable
Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects Start of enrollment: 2008 Apr 01
Completed
Phase 2
Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects Start of enrollment: 2010 Sep 01
Active, not recruiting
Phase 1
Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay Start of enrollment: 2014 Jan 01
Completed
Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV Infection
Withdrawn
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

HBI: a hierarchical Bayesian interaction model to estimate cell-type-specific methylation quantitative trait loci incorporating priors from cell-sorted bisulfite seque...
Youshu Cheng, Biao Cai, Hongyu Li, Xinyu Zhang, Gypsyamber D'Souza
Genome Biology. 2024-10-15
Awareness, treatment, and control of hypertension among women at risk or living with HIV in the US South.
Jessica Blair, Mirjam-Colette Kempf, Jodie A Dionne, Zenoria Causey-Pruitt, Jenni M Wise
AIDS. 2024-09-01
A simple phylogenetic approach to analyze hypermutated HIV proviruses reveals insights into their dynamics and persistence during antiretroviral therapy.
Aniqa Shahid, Bradley R Jones, Maggie C Duncan, Signe MacLennan, Michael J Dapp
Research Square. 2024-06-13

Press Mentions

Veteran HIV/AIDS Researcher Helps Uncover a New Strategy Behind Potential CureMay 4th, 2022
Clinics Offer Hope to COVID-19 ‘Long-Hauler’ PatientsJuly 29th, 2021
Worth the Weight: Using Inverse Probability Weighted Cox Models in AIDS ResearchDecember 1st, 2019
Join now to see all

Grant Support

Miami HIV/AIDS Clinical Therapeutic And Vaccine Trial UnitNational Institute Of Allergy And Infectious Diseases2007–2012
Clinical SciencesNational Institute Of Allergy And Infectious Diseases2007–2011
Miami Adult AIDS Clinical Trials Group, AactgNational Institute Of Allergy And Infectious Diseases2000–2006
Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
Outreach AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
Neurology AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases1996–1999
Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
Adult AIDS Clinical Trials Unit ACTGNational Institute Of Allergy And Infectious Diseases1996–1999
AIDS Associated Malignancies Clinical TrialsNational Cancer Institute1995–1998
AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1995
Therapy With A TAT Antagonist For Kaposi'S SarcomaNational Cancer Institute1993–1994
Adult AIDS Clinical Trials Unit (ACTUS)National Institute Of Allergy And Infectious Diseases1992–1993
Heterosexual And Household Transmission Of HIV-1National Cancer Institute1991–1993
Establishment Of AIDS Treatment Evaluation UnitsNational Institute Of Allergy And Infectious Diseases1988–1991
Heterosexual Transmission Of HIVNational Institute Of Allergy And Infectious Diseases1987–1991
Heterosexual And Household Transmission Of HTLV-IIINational Cancer Institute1989–1990
Heterosexual And Household Tranmission Of HTLV-IIINational Cancer Institute1986–1988
A Study Of An Acquired Immunodeficiency SyndromeNational Cancer Institute1985

MargaretAFischlMD

Dr. Fischl is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Grant Support

Viewing the full profile is available to verified healthcare professionals only.